Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2026-05-17 @ 3:29 PM
Study NCT ID:
NCT00069758
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2003-09-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma
Sponsor:
Organization: